Celera news from FierceBiotech
NewsCelera completes its corporate transformation
Celera has ended its run as a biotech drug developer, completing its switch to molecular diagnostic testing company and moving its HQ from Rockville, MD to Alameda California. The Baltimore Business Read more...
ALSO NOTED: Crucell shares up on TB data; Celera, Merck ink cancer deal; and much more...
> A federal patent office may appeal a court ruling that threw out a new cap limiting the number of times a company can resubmit patent applications. That change was aggressively contested by the Read more...
ALSO NOTED: Novartis teams up with MIT; EMEA approves Galvus; and much more...
> Novartis is teaming up with MIT to develop new ways to manufacture drugs. The company will give the university $65 million over 10 years to create a new research program. Read more...
Celera acquires Atria assets for $33M
Celera will acquire all of the assets of Atria for approximately $33 million in cash. Atria has a line of human leukocyte antigen (HLA) testing products that are used for identifying potential Read more...
ALSO NOTED: Teva invests in stem cell start-up; Anacor files for IPO; Merrion sets terms; and much more...
> Teva is investing $1 million in the stem cell start-up Cell Cure Neurosciences. Report > Anacor Read more...
| Press ReleasesCelera Genomics Group-an Applera Corp. Business Grants License to Merck for Cancer Targets Celera Genomics Group-an Applera Corp. Business Grants License to Merck for Cancer Targets /10/2008 ALAMEDA, Calif. -- Celera, an Applera Corporation business, today announced a two year exclusive Read more... PRESS RELEASE: Celera Announces Clinical Milestone Payment from Merck Celera Announces Clinical Milestone Payment from Merck ROCKVILLE, Md. & ALAMEDA, Calif. -- Celera, an Applera Corporation business, today announced a clinical milestone payment of $2 million Read more... PRESS RELEASE: Celera to Acquire Atria Genetics Celera to Acquire Atria Genetics Acquisition Complements Celera's Existing Molecular Diagnostics Portfolio and Provides High Margin Products ROCKVILLE, Md. & ALAMEDA, Calif. -- Celera, an Read more... PRESS RELEASE: Celera to Acquire Berkeley HeartLab Celera to Acquire Berkeley HeartLab, Inc. Acquisition provides Celera with CLIA-certified laboratory to commercialize its broad portfolio of new tests & vehicle to deliver personalized disease Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets